Here’s what you should know:
1. The index fund surged 39 percent in 2017. Exact Sciences and Foundation Medicine both led the fund nearly tripling their value throughout the year.
2. The index fund has 26 total stocks in it.
3. The index fund’s overall performance was positive. Nineteen of the 26 companies had stocks that gained value in 2017. Seven firms suffered year-over-year losses. Of the gainers, four rose by triple-digit percentages.
4. Exact Sciences’ value increased by a total of 293 percent year-over-year.
More articles on gastroenterology:
GI leader to know: Dr. Elisa Faybush of Arizona Digestive Health
Allergan, Karl Storz Endoscopy & more — 4 GI company key notes
Low-dose polyethylene glycol-based bowel preparation solution acceptable — 4 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.